Announcement

Collapse
No announcement yet.

Tabebuia avellanedaenaphthoquinones: activity against methicillin-resistant staphylococcal strains, cytotoxic activity and in vivodermal irritability analysis

Collapse
X
Collapse
 
  • Page of 1
  • Filter
  • Time
  • Show
Clear All
new posts
Previous template Next
  • #1

    Tabebuia avellanedaenaphthoquinones: activity against methicillin-resistant staphylococcal strains, cytotoxic activity and in vivodermal irritability analysis

    Annals of Clinical Microbiology and Antimicrobials
    http://www.ann-clinmicrob.com

    Research
    Tabebuia avellanedaenaphthoquinones: activity against methicillin-resistant staphylococcal strains, cytotoxic activity and in vivodermal irritability analysis
    Eliezer M Pereira, Thelma B Machado, Ivana CR Leal, Desiree M Jesus, Clarissa RA Damaso, Antonio V Pinto, Marcia Giambiagi-deMarval, Ricardo M Kuster, Katia RN Santos
    Annals of Clinical Microbiology and Antimicrobials 2006, 5:5 (22 March 2006)
    [Abstract] [Provisional PDF]


    Research
    Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States
    David Styers, Daniel J Sheehan, Patricia Hogan, Daniel F Sahm
    Annals of Clinical Microbiology and Antimicrobials 2006, 5:2 (9 February 2006)
    [Abstract] [Full Text] [PDF] [PubMed] [Related articles]
    Tags: None
  • #2
    Re: Annals of Clinical Microbiology and Antimicrobials

    Ventilator associated pneumonia and infection control
    Emine E Alp and Andreas A Voss

    Annals of Clinical Microbiology and Antimicrobials 2006, 5:7 doi:10.1186/1476-0711-5-7

    Published 6 April 2006

    Abstract (provisional)

    Ventilator associated pneumonia (VAP) is the leading cause of morbidity and mortality in intensive care units. The incidence of VAP varies from 7% to 70% in different studies and the mortality rates are 20-75% according to the study population. Aspiration of colonized pathogenic microorganisms on the oropharynx and gastrointestinal tract is the main route for the development of VAP. On the other hand, the major risk factor for VAP is intubation and the duration of mechanical ventilation. Diagnosis remains difficult, and studies showed the importance of early initiation of appropriate antibiotic for prognosis. VAP causes extra length of stay in hospital and intensive care units and increases hospital cost. Consequently, infection control policies are more rational and will save money.

    PDF
    http://www.ann-clinmicrob.com/content/pdf/1476-0711-5-7.pdf


    Ventilator associated pneumonia and infection control - Annals of Clinical Microbiology and Antimicrobials
    http://www.ann-clinmicrob.com/content/5/1/7
    Ventilator associated pneumonia (VAP) is the leading cause of morbidity and mortality in intensive care units. The incidence of VAP varies from 7% to 70% in different studies and the mortality rates are 20–75% according to the study population. Aspiration of colonized pathogenic microorganisms on the oropharynx and gastrointestinal tract is the main route for the development of VAP. On the other hand, the major risk factor for VAP is intubation and the duration of mechanical ventilation. Diagnosis remains difficult, and studies showed the importance of early initiation of appropriate antibiotic for prognosis. VAP causes extra length of stay in hospital and intensive care units and increases hospital cost. Consequently, infection control policies are more rational and will save money.

    Comment

    • #3
      Re: Annals of Clinical Microbiology and Antimicrobials

      Is VAP the same as ARDS? Or is an ARDS a result of the intubation without proper treatment of the underlying pathogen(s)?

      If H5N1 goes H2H, there may be lots of people on ventilators due to cytokine storm and resulting ARDS.....

      It seems that lots of research is going into H5N1... how much research is happening to reduce the cytokine storm and ARDS?

      Sorry for all the questions.... I learn by asking questions.
      "Predictable is Preventable" by Safety Expert Dr. Gordon Graham.

      Comment

      • #4
        Re: Annals of Clinical Microbiology and Antimicrobials

        No Lob.

        Vap is Ventilator Associated Pneumonia, while
        ARDS is Acute Respiratory Distress Syndrome.

        Comment

        • #5
          Re: Annals of Clinical Microbiology and Antimicrobials

          ARDS can happen without intubation or Ventilation.

          Comment

          • #6
            Re: Annals of Clinical Microbiology and Antimicrobials

            I have learned "a little bit about ARDS" in my life. My father had three lobes of his lungs removed due to cancer and was on a ventilator for a short period during surgery. He developed ARDS and survived for three years. He is mentioned in "journals" as a case worth mentioning due to his atypical recovery. (No B.S. here). He lived for three years with only two lobes of his lung after recovering from ARDS.

            I have also been actively studying the works of Dr. James Reason. ARDS is an area that his work has been actively applied to.

            I want to know the similarities and the differences between VAP and ARDS (if there are any). Don't give me the short answer, I have already heard it and am well beyond that knowledge level. It looks like a duck and quacks like a duck to me.
            "Predictable is Preventable" by Safety Expert Dr. Gordon Graham.

            Comment

            • #7
              Re: Annals of Clinical Microbiology and Antimicrobials

              Lob,

              I am not a specialist, I have only stated what I recall in my lecture of litterature.

              You seems more knowledgeable than I on this matter, I feel that you do have a lot to say about this.

              Please allow yourself, I am always eager to learn, specifically on ARDS and VAP. since we might have to deal with these more often than willing to.

              Comment

              Previous template Next
              Working...
              X